Page last updated: 2024-08-24

ferric citrate and pd 98059

ferric citrate has been researched along with pd 98059 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kwon, TK; Lee, TJ; Park, JW; Woo, KJ1
Jang, HJ; Jeon, BH; Jun, CD; Kim, EC; Lee, HJ; Lee, J; Lee, SK1

Other Studies

2 other study(ies) available for ferric citrate and pd 98059

ArticleYear
Desferrioxamine, an iron chelator, enhances HIF-1alpha accumulation via cyclooxygenase-2 signaling pathway.
    Biochemical and biophysical research communications, 2006, Apr-28, Volume: 343, Issue:1

    Topics: Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Deferoxamine; Ferric Compounds; Flavonoids; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Iron Chelating Agents; Mitogen-Activated Protein Kinases; Signal Transduction; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2006
p38 and ERK MAP kinase mediates iron chelator-induced apoptosis and -suppressed differentiation of immortalized and malignant human oral keratinocytes.
    Life sciences, 2006, Sep-05, Volume: 79, Issue:15

    Topics: Apoptosis; Caspase 3; Caspase 8; Caspases; Cell Differentiation; Cell Proliferation; Cytochromes c; Deferoxamine; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Ferric Compounds; Flavonoids; Humans; Imidazoles; Iron Chelating Agents; Keratinocytes; Mouth Neoplasms; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Precursors; Pyridines

2006